Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,078,552 papers from all fields of science
Search
Sign In
Create Free Account
gabapentin enacarbil
Known as:
Gabapentine enacarbil
, Gabapentinum enacarbilum
, Gabapentina enacarbilo
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Antiepileptic Agents
Bipolar Disorder
Drug Allergy
Epilepsies, Partial
Expand
Narrower (2)
Horizant
XP13512
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report
Masahiro Takeshima
,
H. Ishikawa
,
Y. Kikuchi
,
T. Kanbayashi
,
T. Shimizu
Clinical Psychopharmacology and Neuroscience
2018
Corpus ID: 52040939
The management of clozapine (CLZ)-induced adverse events affects patient prognoses. Akathisia is a relatively rare adverse event…
Expand
2018
2018
Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
Masahiro Takeshima
,
H. Ishikawa
,
T. Kanbayashi
,
T. Shimizu
Neuropsychiatric Disease and Treatment
2018
Corpus ID: 54479676
Objective Gabapentin and its prodrug are candidate therapeutic agents for akathisia. An open-label pilot study was conducted to…
Expand
2015
2015
Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison.
Chao Chen
,
J. Upward
,
T. Arumugham
,
Brendt Stier
,
M. Davy
Clinical Therapeutics
2015
Corpus ID: 33336830
2015
2015
The Effect of Gabapentin Enacarbil (GEn) on Quality-of-Life (QoL) Outcomes in Adult Patients With Moderate-to-Severe and Severe Primary Restless Legs Syndrome (RLS): Pooled Analyses From Two 12-Week…
A. Avidan
,
S. Isaacson
,
M. Jaros
,
R. Kim
,
G. Shang
Neurology
2015
Corpus ID: 70532828
OBJECTIVE: To determine the effect of GEn on QoL in adults with moderate-to-severe and severe primary RLS. BACKGROUND: Poor QoL…
Expand
Review
2014
Review
2014
Gabapentin for the prophylaxis of episodic migraine in adults.
Corey D. Fogleman
American Family Physician
2014
Corpus ID: 9486853
Gabapentin does not decrease the frequency of migraine headaches and is not recommended for prophylactic therapy.
2011
2011
NEUROPATHIC PAIN SECTION Original Research Articles Efficacy of Gabapentin Enacarbil vs Placebo in Patients with Postherpetic Neuralgia and a Pharmacokinetic Comparison with Oral Gabapentin
M. Backonja
,
D. Canafax
,
K. Cundy
,
D. Canafax
2011
Corpus ID: 21849081
Background. The efficacy of gabapentin in some patients with postherpetic neuralgia (PHN) may be limited by suboptimal drug…
Expand
2011
2011
A phase I, single-dose study of the disposition of 14C-radiolabeled gabapentin enacarbil in healthy male volunteers.
R. Lal
,
J. Sukbuntherng
,
J. Ho
,
K. Cundy
International journal of clinical pharmacology…
2011
Corpus ID: 5743749
UNLABELLED Gabapentin enacarbil (GEn) is a prodrug of gabapentin that is effective in restless legs syndrome (RLS) and has dose…
Expand
Review
2011
Review
2011
Gabapentin enacarbil for the treatment of restless legs syndrome (RLS)
R. A. Burke
,
M. Faulkner
Expert Opinion on Pharmacotherapy
2011
Corpus ID: 24410892
Introduction: Gabapentin enacarbil is a new treatment for restless legs syndrome (RLS). It is a prodrug of the anticonvulsant…
Expand
2011
2011
Gabapentin encarbil (Horizant) for restless leg syndrome.
The Medical letter on drugs and therapeutics
2011
Corpus ID: 9367642
Gabapentin enacarbil (Horizant-GlaxoSmithKline), a new extended-release (ER) tablet formulation of gabapentin, has been approved…
Expand
2009
2009
Procédé de synthèse et de purification de gabapentine enacarbil
Elena Ben-Moha-Lerman
,
Tamar Nidam
,
Meital Cohen
,
Sharon Avhar-Maydan
,
Anna Balanov
2009
Corpus ID: 103731942
Le medicament Gabapentine enacarbil est synthetise et purifie a partir d'intermediaires comme un carbamate ou carbonate de 1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE